Dr. Chilukuri highlighted the evolving field of regenerative medicine and its crossover with other anti-inflammatory disciplines based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA CME Conference. He explored how the body’s natural capacity to heal scarlessly during infancy diminishes with age, sparking interest in new tools that can replicate that early healing process. Key treatments discussed included exosomes to control initial wound inflammation and polynucleotides, derived from salmon DNA, to improve the overall appearance of both old and new scars. Additionally, he covered how neuromodulators, including upcoming options like botulinum type E, can be used on wounds to downregulate immune factors that lead to abnormal scarring.
